Aryl hydrocarbon receptor ligands that block myofibroblast formation and collagen production in thyroid eye disease may be the key, according to a new report in The American Journal of Pathology ...
Research findings from the University of Rochester shows new hope for the treatment of Graves’ disease and thyroid eye disease. Activation of the aryl hydrocarbon receptor (AHR) pathway by its ligand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results